SEQSTER and PatientsLikeMe Launch National Rare Disease Study

SEQSTER and PatientsLikeMe (PLM) have collaborated to launch a rare-disease study focused on Alpha-1 Antitrypsin Deficiency (AATD). The study aims to better understand how to reduce delays in diagnosis, decrease disparities in care, and improve outcomes in patients with AATD.

Read more about the study here.